RESUMEN
The exact mechanism by which knockout of Toll-like receptor 4 (TLR4) attenuates the liver injury remains unclear. The present study aimed to examine the role of TLR4 in the pathogenesis of bile duct ligation (BDL)-induced liver cholestatic injury and the underlying mechanism. Wild type (WT) mice and TLR4 knockout (TLR4-KO) mice were used for the establishment of the BDL model. Metabolomics were applied to analyze the changes of small molecular metabolites in the serum and liver of the two groups. The serum biochemical indexes and the HE staining results of liver tissue showed that liver damage was significantly reduced in TLR4-KO mice after BDL when compared with that in WT mice. The metabolite analysis results showed that TLR4 KO could maintain the metabolisms of amino acids- and choline-related metabolites. After BDL, the amino acids- and choline-related metabolites, especially choline and 3-hydroxybutyrate, were significantly increased in WT mice (both in serum and liver), but these metabolites in the liver of TLR4-KO mice after BLD were not significant different from those before BLD. In conclusion, TLR4 KO could attenuate BDL-induced liver cholestatic injury through regulating amino acid and choline metabolic pathways.
Asunto(s)
Colestasis/genética , Hígado/metabolismo , Redes y Vías Metabólicas/genética , Receptor Toll-Like 4/genética , Aminoácidos/metabolismo , Animales , Conductos Biliares/patología , Colestasis/etiología , Colestasis/patología , Colina/metabolismo , Humanos , Ligadura/efectos adversos , Hígado/lesiones , Ratones , Ratones NoqueadosRESUMEN
Temporomandibular disorder (TMD) is commonly comorbid with fibromyalgia syndrome (FMS). The incidence of these pain conditions is prevalent in women and prone to mental stress. Chronic pain symptoms in patients with FMS and myofascial TMD (mTMD) are severe and debilitating. In the present study, we developed a new animal model to mimic the comorbidity of TMD and FMS. In ovariectomized female rats, repeated forced swim (FS) stress induced mechanical allodynia and thermal hyperalgesia in the hindpaws of the 17ß-estradiol (E2) treated rats with orofacial inflammation. Subcutaneous injection of E2, injection of complete Freund's adjuvant (CFA) into masseter muscles or FS alone did not induce somatic hyperalgesia. We also found that the somatic hyperalgesia was accompanied by upregulation of GluN1 receptor and serotonin (5-hydroxytryptamine, 5-HT)3A receptor expression in the dorsal horn of spinal cord at L4-L5 segments. Intrathecal injection of N-methyl-D-aspartic acid receptor (NMDAR) antagonist 2-amino-5-phosphonovaleric acid (APV) or 5-HT3 receptor antagonist Y-25130 blocked stress-induced wide-spreading hyperalgesia. These results suggest that NMDAR-dependent central sensitization in the spinal dorsal horn and 5-HT-dependent descending facilitation contribute to the development of wide-spreading hyperalgesia in this comorbid pain model.
Asunto(s)
Sensibilización del Sistema Nervioso Central , Hiperalgesia/etiología , Hiperalgesia/fisiopatología , Inflamación/fisiopatología , Boca/patología , Estrés Psicológico/complicaciones , Animales , Cara/patología , Femenino , Inflamación/patología , Ratas Sprague-Dawley , Receptores de N-Metil-D-Aspartato/metabolismo , Receptores de Serotonina 5-HT3/metabolismo , Natación , TemperaturaRESUMEN
The micro-environment formed by the photosynthesis of submerged plants is conducive to the formation of CaCO3-P from co-precipitation of calcium and phosphorus in water, thereby permanently removing phosphorus from water to the bottom mud and avoiding secondary pollution after plants decay. However, CaCO3-P co-precipitation shows obvious specific-differences and environmental dependencies. In the present study, two different submerged plants, Myriophyllum aquaticum and Potamogeton crispus, were used as the research objects. Two variables, inorganic phosphorus level (0, 0.2, and 2 mg·L-1) and light intensity [66 µmol·(m2·s)-1 and 110 µmol·(m2·s)-1], were set. After cultivating for a week, the plant relative growth rate, plant total phosphorus, plant ash phosphorus, and Ca-P were measured to analyze the actual ability of phosphorus accumulation and clarify the effect of plant corruption on phosphorus increase in the water body. Results revealed that under various culture conditions, the relative growth rates (RGR) of P. crispus were significantly higher than those of M. aquaticum, and RGR reached the maximum at a P level of 2 mg·L-1 and a light intensity of 66 µmol·(m2·s)-1. The addition of inorganic phosphorus significantly affected plant ash phosphorus of the two plants (P. crispus 95.681%, M. aquaticum 85.432%), and the highest value of Ca-P content in the ash phosphorus of the two submerged plants appeared at a high phosphorus level. The total phosphorus in P. crispus was lower than that in M. aquaticum under various treatments, but the total ash phosphorus and Ca-P levels were higher than those in M. aquaticum. Consequently, M. aquaticum and P. crispus can effectively accumulate phosphorus during growth. However, the actual ability of P. crispus of removing phosphorus from water by the formation of CaCO3-P was higher than that of M. aquaticum at a P level of 2 mg·L-1.
Asunto(s)
Fósforo , Potamogetonaceae , Luz , Nitrógeno , SaxifragalesRESUMEN
Bone marrow stromal cells (BMSCs) produce long-lasting attenuation of pain hypersensitivity. This effect involves BMSC's ability to interact with the immune system and activation of the endogenous opioid receptors in the pain modulatory circuitry. The nuclear factor kappa B (NF-κB) protein complex is a key transcription factor that regulates gene expression involved in immunity. We tested the hypothesis that the NF-κB signaling plays a role in BMSC-induced pain relief. We focused on the rostral ventromedial medulla (RVM), a key structure in the descending pain modulatory pathway, that has been shown to play an important role in BMSC-produced antihyperalgesia. In Sprague-Dawley rats with a ligation injury of the masseter muscle tendon (TL), BMSCs (1.5 M/rat) from donor rats were infused i.v. at 1 week post-TL. P65 exhibited predominant neuronal localization in the RVM with scattered distribution in glial cells. At 1 week, but not 8 weeks after BMSC infusion, western blot and immunostaining showed that p65 of NF-κB was significantly increased in the RVM. Given that chemokine signaling is critical to BMSCs' pain-relieving effect, we further evaluated a role of chemokine signaling in p65 upregulation. Prior to infusion of BMSCs, we transduced BMSCs with Ccl4 shRNA, incubated BMSCs with RS 102895, a CCR2b antagonist, or maraviroc, a CCR5 antagonist. The antagonism of chemokines significantly reduced BMSC-induced upregulation of p65, suggesting that upregulation of p65 was related to BMSCs' pain-relieving effect. We then tested the effect of a selective NF-κB activation inhibitor, BAY 11-7082. The mechanical hyperalgesia of the rat was assessed with the von Frey method. In the pre-treatment experiment, BAY 11-7082 (2.5 and 25 pmol) was injected into the RVM at 2 h prior to BMSC infusion. Pretreatment with BAY 11-7082 attenuated BMSCs' antihyperalgesia, but post-treatment at 5 weeks post-BMSC was not effective. On the contrary, in TL rats receiving BAY 11-7082 without BMSCs, TL-induced hyperalgesia was attenuated, consistent with dual roles of NF-κB in pain hypersensitivity and BMSC-produced pain relief. These results indicate that the NF-κB signaling pathway in the descending circuitry is involved in initiation of BMSC-produced behavioral antihyperalgesia.
RESUMEN
As(III) is the most harmful substance of all over 20 kinds of arsenic compounds. In addition, the trivalent oxidation state of arsenic is not stable, which can be oxidized to pentavalent arsenic. Thus, it is attractive and challenging to sensitively and selectively monitor As(III) concentration, rather than As(V) concentration, in water. However, most of detection techniques suffer from the inability to distinguish As(III) and As(V), or even need specialized personnel and additional equipment. Herein, novel luminescent Ce(III)-based coordination polymer nanoparticles (Ce-CPNs) have been proposed for selective detection of As(III). The Ce-CPNs are dispersive and show a fluorescence peak at 353â¯nm under excitation at 280â¯nm. With the presence of As(III), aggregation of Ce-CPNs occurs, resulting in quenching of the fluorescent Ce-CPNs due to the aggregation-caused π-π stacked layers of Ce-CPNs. Under optimal conditions, the detection limit for As(III) is down to 0.7 ppb. In addition, the Ce-CPNs are selective for As(III) over other ions and has been successfully applied for fluorescence sensing of As(III) in environmental water samples.
RESUMEN
Systemic infusion of bone marrow stromal cells (BMSCs), a major type of multipotent stromal cells, produces pain relief (antihyperalgesia) that lasts for months. However, studies have shown that the majority of BMSCs are trapped in the lungs immediately after intravenous infusion and their survival time in the host is inconsistent with their lengthy antihyperalgesia. Here we show that long-lasting antihyperalgesia produced by BMSCs required their chemotactic factors such as CCL4 and CCR2, the integrations with the monocytes/macrophages population, and BMSC-induced monocyte CXCL1. The activation of central mu-opioid receptors related to CXCL1-CXCR2 signaling plays an important role in BMSC-produced antihyperalgesia. Our findings suggest that the maintenance of antihypergesia can be achieved by immune regulation without actual engraftment of BMSCs. In the capacity of therapeutic use of BMSCs other than structural repair and replacement, more attention should be directed to their role as immune modulators and subsequent alterations in the immune system.
Asunto(s)
Hiperalgesia/inmunología , Células Madre Mesenquimatosas/inmunología , Dolor/inmunología , Animales , Quimiocina CCL4/metabolismo , Quimiocina CXCL1/metabolismo , Femenino , Macrófagos/inmunología , Masculino , Ratas , Ratas Sprague-Dawley , Receptores CCR2/metabolismo , Receptores Opioides mu/metabolismo , Transducción de SeñalRESUMEN
BACKGROUND: Bone marrow stromal cells (BMSCs) have shown potential to treat chronic pain, although much still needs to be learned about their efficacy and mechanisms of action under different pain conditions. Here, we provide further convergent evidence on the effects of BMSCs in rodent pain models. RESULTS: In an orofacial pain model involving injury of a tendon of the masseter muscle, BMSCs attenuated behavioral pain conditions assessed by von Frey filaments and a conditioned place avoidance test in female Sprague-Dawley rats. The antihyperalgesia of BMSCs in females lasted for <8 weeks, which is shorter than that seen in males. To relate preclinical findings to human clinical conditions, we used human BMSCs. Human BMSCs (1.5 M cells, i.v.) attenuated mechanical and thermal hyperalgesia induced by spinal nerve ligation and suppressed spinal nerve ligation-induced aversive behavior, and the effect persisted through the 8-week observation period. In a trigeminal slice preparation, BMSC-treated and nerve-injured C57B/L mice showed reduced amplitude and frequency of spontaneous excitatory postsynaptic currents, as well as excitatory synaptic currents evoked by electrical stimulation of the trigeminal nerve root, suggesting inhibition of trigeminal neuronal hyperexcitability and primary afferent input by BMSCs. Finally, we observed that GluN2A (N-methyl-D-aspartate receptor subunit 2A) tyrosine phosphorylation and protein kinase Cgamma (PKCg) immunoreactivity in rostral ventromedial medulla was suppressed at 8 weeks after BMSC in tendon-injured rats. CONCLUSIONS: Collectively, the present work adds convergent evidence supporting the use of BMSCs in pain control. As PKCg activity related to N-methyl-D-aspartate receptor activation is critical in opioid tolerance, these results help to understand the mechanisms of BMSC-produced long-term antihyperalgesia, which requires opioid receptors in rostral ventromedial medulla and apparently lacks the development of tolerance.
Asunto(s)
Conducta Animal , Encéfalo/patología , Trasplante de Células Madre Mesenquimatosas , Células Madre Mesenquimatosas/citología , Neuralgia/terapia , Animales , Modelos Animales de Enfermedad , Potenciales Postsinápticos Excitadores/efectos de los fármacos , Femenino , Humanos , Masculino , Células Madre Mesenquimatosas/efectos de los fármacos , Células Madre Mesenquimatosas/metabolismo , Ratones Endogámicos C57BL , Naloxona/farmacología , Neuralgia/metabolismo , Neuralgia/patología , Fosforilación/efectos de los fármacos , Proteína Quinasa C/metabolismo , Ratas Sprague-Dawley , Receptores de N-Metil-D-Aspartato/metabolismo , Sinapsis/efectos de los fármacos , Sinapsis/patología , Tendones/efectos de los fármacos , Tendones/patología , Nervio Trigémino/efectos de los fármacos , Nervio Trigémino/patologíaRESUMEN
OBJECTIVE: To compare the differences in the efficacy on distant version of naked eye in the patients of juvenile myopia between rotating manipulation and lifting-thrusting manipulation of acupuncture. METHODS: One hundred and twenty cases (240 eyes) were randomized into a rotating manipulation group and a lifting-thrusting manipulation group, 60 cases (120 eyes) in each group. Additionally, a corrective lenses group, 60 cases (120 eyes), was set up as the control. In both manipulation groups, Cuanzhu (BL 2),Yuyao (EX-HN 4), Sizhukong (TE 23), Taiyang (EX-HN 5), Fengchi (GB 20), Zusanli (ST 36), Guangming (GB 37) and Sanyinjiao (SP 6) were punctured, but stimulated with rotating manipulation and lifting-thrusting manipulation respectively three times per week, 10 times as a treatment session and totally one session was required. In the corrective lenses group, the glasses were applied at daytime. The clinical efficacy and the changes in distant vision of naked eye before and after treatment were compared among the three groups. RESULTS: The total effective rate was 87.5% (105/120) in the rotating manipulation group, which was better than 69.2% (83/120) in the lifting-thrusting manipulation group (P < 0.05). The distant vision of naked eye was improved apparently in the rotating manipulation group and the lifting-thrusting manipulation group after treatment (both P < 0.05). But it was not improved in the corrective lenses group (P > 0.05). The distant vision of naked eye was improved more apparently after treatment in the rotating manipulation group as compared with that in the lifting-thrusting manipulation group (0.75 +/- 0.23 vs 0.68 +/- 0.24, P < 0.05). For 96 cases (192 eyes) with acupuncture treatment, in 3-month follow-up, 87.0% (167/192) of the cases maintained the stable vision as the original level and 13.0% (25/192) of them were reduced in the vision In the acupuncture groups, it was found that the improvement of distant vision of naked eye was more obvious after treatment with younger age, better basic vision and shorter duration of sickness (all P < 0.05). CONCLUSION: Acupuncture achieves the positive and sustainable clinical effect on juvenile myopia, and the results of rotating manipulation are superior to that of lifting-thrusting manipulation. Age, basic vision and duration of sickness impact the clinical efficacy.
Asunto(s)
Terapia por Acupuntura , Miopía/terapia , Puntos de Acupuntura , Terapia por Acupuntura/instrumentación , Terapia por Acupuntura/métodos , Adolescente , Niño , Femenino , Humanos , Adulto JovenRESUMEN
Dexmedetomidine, a selective alpha 2-adrenoceptor (α2AR) agonist, has provided significant analgesia in neuropathic pain. However, its underlying molecular mechanism has not been fully elucidated. In the present study, we found that intrathecal administration of dexmedetomidine alleviated mechanical allodynia induced by chronic constriction injury (CCI), and pretreatment with BRL44408 significantly reversed the dexmedetomidine-induced anti-nociceptive effect. Western blotting revealed that dexmedetomidine reduced the activation of microglia and the upregulation of interleukin-18 (IL-18) protein expression in the ipsilateral lumbar spinal dorsal horn, while BRL44408 pretreatment significantly blocked these effects of dexmedetomidine. Immunocytochemistry/immunohistochemistry indicated that the α2A-adrenoceptor was localised to microglia in primary culture, and IL-18 predominantly colocalised with the microglial marker Iba-1 in the dorsal horn of the spinal cord. These results suggest that the IL-18 signalling pathway in microglia may be involved in the anti-nociceptive effect of dexmedetomidine in rats subjected to CCI.
Asunto(s)
Analgésicos no Narcóticos/farmacología , Dexmedetomidina/farmacología , Interleucina-18/metabolismo , Microglía/metabolismo , Traumatismos de la Médula Espinal/tratamiento farmacológico , Médula Espinal/efectos de los fármacos , Analgésicos no Narcóticos/uso terapéutico , Animales , Células Cultivadas , Enfermedad Crónica , Constricción Patológica , Dexmedetomidina/uso terapéutico , Hiperalgesia/tratamiento farmacológico , Hiperalgesia/metabolismo , Hiperalgesia/fisiopatología , Masculino , Umbral del Dolor , Estimulación Física , Células del Asta Posterior/efectos de los fármacos , Células del Asta Posterior/metabolismo , Ratas Sprague-Dawley , Receptores Adrenérgicos alfa 2/metabolismo , Médula Espinal/metabolismo , Traumatismos de la Médula Espinal/metabolismo , Traumatismos de la Médula Espinal/fisiopatología , TactoRESUMEN
Tetanic stimulation of the sciatic nerve (TSS) induces sciatic nerve injury and long-lasting pain hypersensitivity in rats, and spinal glial activation and proinflammatory cytokines releases are involved. In the present study, we showed that spinal interleukin (IL)-23 and its receptor, IL-23R, are crucial for the development of mechanical allodynia after TSS. In the spinal dorsal horn, both IL-23 and IL-23R are expressed in astrocytes, and this expression is substantially increased after TSS. Inhibition of IL-23 signaling attenuated TSS-induced allodynia and decreased the induction of glial fibrillary acidic protein (GFAP, an astrocytic marker). Conversely, intrathecally delivered IL-23 induced a persistent allodynia. Similar to IL-23 signaling, an increase in IL-18 and its receptor, IL-18R, as well as CX3CL1 and its receptor, CX3CR1, was simultaneously observed in the spinal dorsal horn after TSS. Interestingly, IL-18 and CX3CR1 were exclusively expressed in microglia, while IL-18R was mainly localized in astrocytes. In contrast, CX3CL1 was predominately expressed in neurons and secondarily in astrocytes. The functional inhibition of CX3CL1 and IL-18 signaling attenuated TSS-induced allodynia and suppressed IL-23 and IL-23R upregulation. Activation of CX3CR1 and IL-18R induced similar behavioral and biochemical changes to those observed after TSS. These results indicate that the interaction among CX3CL1, IL-18 and IL-23 signaling in the spinal cord plays a critical role in the development of allodynia. Thus, interrupting this chemokine-cytokine network might provide a novel therapeutic strategy for neuropathic pain.
Asunto(s)
Quimiocina CX3CL1/metabolismo , Hiperalgesia/metabolismo , Interleucina-18/metabolismo , Interleucina-23/metabolismo , Células del Asta Posterior/metabolismo , Receptores de Interleucina-18/metabolismo , Animales , Estimulación Eléctrica , Masculino , Ratas , Ratas Sprague-Dawley , Receptores de Interleucina/metabolismo , Nervio Ciático , Transducción de Señal , Regulación hacia ArribaRESUMEN
BACKGROUND: Spinal glia, particularly microglia and astrocytes, are of the utmost importance in the development and maintenance of chronic pain. A recent study from our laboratory revealed that gabapentin, a recommended first-line treatment for multiple neuropathic conditions, could also efficiently antagonize thermal hyperalgesia evoked by complete Freund's adjuvant (CFA)-induced monoarthritis (MA). In the present study, we investigated whether the spinal glia are involved in the anti-hyperalgesic effect of gabapentin and how this event occurs. RESULTS: Unilateral intra-articular injection of CFA produced a robust activation of microglia and astrocytes. These cells exhibited large cell bodies, thick processes and increases in the ionized calcium binding adapter molecule 1 (Iba-1, a microglial marker) or the glia fibrillary acidic protein (GFAP, an astrocytic marker). These cells also displayed immunoreactive signals, and an upregulation of the voltage-gated calcium channels (VGCCs) α2/δ-1 subunit, CX3CL1 and CX3CR1 expression levels in the spinal cord. These changes were associated with the development of thermal hyperalgesia. Immunofluorescence staining showed that VGCC α2/δ-1 subunit, a proposed gabapentin target of action, was widely distributed in primary afferent fibers terminals and dorsal horn neurons. CX3CL1, a potential trigger to activate microglia, colocalized with VGCC α2/δ-1 subunits in the spinal dorsal horn. However, its receptor CX3CR1 was mainly expressed in the spinal microglia. Multiple intraperitoneal (i.p.) gabapentin injections (100 mg/kg, once daily for 4 days with the first injection 60 min before intra-articular CFA) suppressed the activation of spinal microglia, downregulated spinal VGCC α2/δ-1 subunits decreased CX3CL1 levels and blocked the development of thermal hyperalgesia in MA rats. CONCLUSIONS: Here we provide the first evidence that gabapentin diminishes CX3CL1 signaling and spinal microglia activation induced by joint inflammation. We also show that the VGCC α2/δ-1 subunits might be involved in these events.
Asunto(s)
Aminas/farmacología , Artritis/patología , Quimiocina CX3CL1/metabolismo , Ácidos Ciclohexanocarboxílicos/farmacología , Microglía/patología , Transducción de Señal/efectos de los fármacos , Médula Espinal/patología , Ácido gamma-Aminobutírico/farmacología , Aminas/administración & dosificación , Animales , Artritis/complicaciones , Artritis/metabolismo , Receptor 1 de Quimiocinas CX3C , Canales de Calcio Tipo L/metabolismo , Ácidos Ciclohexanocarboxílicos/administración & dosificación , Modelos Animales de Enfermedad , Adyuvante de Freund , Gabapentina , Hiperalgesia/complicaciones , Hiperalgesia/metabolismo , Hiperalgesia/patología , Inyecciones Intraarticulares , Inyecciones Intraperitoneales , Vértebras Lumbares/patología , Masculino , Microglía/efectos de los fármacos , Microglía/metabolismo , Modelos Biológicos , Dolor/metabolismo , Dolor/patología , Células del Asta Posterior/efectos de los fármacos , Células del Asta Posterior/metabolismo , Células del Asta Posterior/patología , Subunidades de Proteína/metabolismo , Ratas , Ratas Sprague-Dawley , Receptores de Quimiocina/metabolismo , Factores de Tiempo , Ácido gamma-Aminobutírico/administración & dosificaciónRESUMEN
Previous studies indicated that disruption of glial function in the spinal cord enhanced electroacupuncture (EA) analgesia in arthritic rats, suggesting glia is involved in processing EA analgesia. To probe into the potential value for clinical practice, the present study was to investigate the effect of propentofylline, a glia inhibitor, on EA analgesia in rats. Mechanical allodynia induced by tetanic stimulation of sciatic nerve (TSS) was used as a pain model. On day 7 after TSS, EA treatment induced a significant increase in paw withdrawal threshold to mechanical stimulation. Intrathecal or intraperitoneal injection of propentofylline relieved TSS-induced mechanical allodynia. The combination of low dosage of propentofylline and EA produced more potent anti-allodynia than propentofylline or EA alone. Immunohistochemistry exhibited that TSS-induced activation of microglia and astrocytes was inhibited significantly by propentofylline. These results indicate that propentofylline and EA induce synergetic analgesia by interrupting spinal glial function.
Asunto(s)
Analgesia , Electroacupuntura/métodos , Médula Espinal/fisiopatología , Xantinas/uso terapéutico , Animales , Hiperalgesia/tratamiento farmacológico , Hiperalgesia/terapia , Masculino , Neuroglía/efectos de los fármacos , Neuroglía/fisiología , Ratas , Ratas Sprague-Dawley , Nervio Ciático/fisiopatología , Médula Espinal/efectos de los fármacos , Tetania/fisiopatologíaRESUMEN
1. Spinal glial cells play a key role in developing and maintaining allodynia and hyperalgesia following tissue inflammation. Dexmedetomidine, a highly selective α(2) -adrenoceptor (α(2) -AR) agonist, has exhibited a significant analgesic effect in various rodent models of chronic pain. However, whether spinal glial activation is involved in the analgesic effect of dexmedetomidine remains unknown. The present study investigated whether spinal administration of dexmedetomidine could antagonize glial activation in the spinal dorsal horn and attenuate thermal hyperalgesia in complete Freund's adjuvant (CFA)-induced ankle joint monoarthritic (MA) rats. 2. Unilateral intra-articular injection of CFA produced a robust activation of microglia and astrocytes in the spinal cord, which was associated with the development and maintenance of thermal hyperalgesia. Repeated lumbar puncture (LP) administration of dexmedetomidine (10 µg) significantly attenuated MA-induced thermal hyperalgesia in a cumulative manner. Monoarthritis-induced spinal glial activation was also suppressed following dexmedetomidine application. The α(2A) -AR, essential for the antinociceptive effects of α(2) -AR agonists, was detected in spinal neurons and glia, as well as in dorsal root ganglion primary afferent neurons, which may be implicated in dexmedetomidine-induced suppression of spinal glial activation and antihyperalgesic effects. 3. These data provide the first evidence that blocking spinal glial activation is involved in the analgesic action of dexmedetomidine.
Asunto(s)
Artritis Experimental/tratamiento farmacológico , Dexmedetomidina/administración & dosificación , Modelos Animales de Enfermedad , Neuroglía/efectos de los fármacos , Médula Espinal/efectos de los fármacos , Agonistas de Receptores Adrenérgicos alfa 2/administración & dosificación , Animales , Artritis Experimental/metabolismo , Artritis Experimental/patología , Adyuvante de Freund/administración & dosificación , Hiperalgesia/metabolismo , Hiperalgesia/prevención & control , Inyecciones Intraarticulares , Masculino , Neuroglía/metabolismo , Neuroglía/patología , Ratas , Ratas Sprague-Dawley , Médula Espinal/metabolismo , Médula Espinal/patologíaRESUMEN
AIM: To investigate the effect of systemic administration dexmedetomidine, a selective alpha 2 adrenergic receptor (alpha(2)AR) agonist, on thermal hyperalgesia and spinal glial activation evoked by monoarthritis (MA). METHODS: MA was induced by an intra-articular injection of complete Freund's adjuvant (CFA). Thermal hyperalgesia was measured by Hargreaves' test. The spinal glial activation status was analyzed by GFAP (an astrocytic marker) and Iba-1 (a microglial marker) immunohistochemistry or immunoblotting. RESULTS: Unilateral intra-articular injection of CFA produced a robust glial activation of astrocytes and microglia in the spinal cord, which was associated with the development and maintenance of thermal hyperalgesia. Intraperitoneal (ip) injection of dexmedetomidine (2.5 and 10 microg/kg) was repeatedly given once daily for 5 days with the first injection 60 min before intra-articular CFA. At the dose of 10 microg/kg, dexmedetomidine significantly attenuated MA-induced ipsilateral hyperalgesia from day 2 to day 5. MA-induced up-regulation of GFAP expression on both sides of the spinal dorsal horn was significantly suppressed by day 5 post-MA following dexmedetomidine application, whereas MA-induced Iba-1 up-regulation was only partially suppressed. CONCLUSION: Systemic dexmedetomidine inhibits the activation of spinal glia, which is possibly associated with its antihyperalgesia in monoarthritic rats.